Streptozotocin (STZ) as a toxic glucose analogue can enter pancreatic β-cell via the glucose transporter GLUT2, cause β-cell necrosis and in turn develop into type 1 diabetes mellitus (T1D) [23]. Here, SLC2A2 is linked to type 1 diabetes mellitus.